TTAB Oppositions 91169856

USPTO Oppositions proceeding 91169856, filed 2006-02-28. Status: Terminated.

Proceeding Facts

Proceeding Number	91169856
Type	Oppositions
Status	Terminated
Filing Date	2006-02-28
Last Activity	2007-04-03
Days Active	7382

Parties

Bio Therapeutics, Inc. — Defendant
SmithKline Beecham PLC, Signal Investment & Management Co., and The Mentholatum Company (jointed as party plaintiffs) — Plaintiff

Plaintiff Marks

No plaintiffs on record.

Defendant Marks

PHYLODERM — Bio Therapeutics, Inc.

Recent Documents

2007-04-03: TERMINATED — Status
2007-04-03: BOARD'S DECISION: SUSTAINED — Decisions
2007-03-30: ABANDONMENT — Miscellaneous
2006-12-22: SUSPENDED — Status
2006-12-22: STIP TO SUSPEND PEND SETTLEMENT NEGOTNS — Motions
2006-10-11: DISC AND TEST DATES REMAIN — Miscellaneous
2006-09-20: P'S MOTION TO SUBSTITUTE OPPOSER — Miscellaneous
2006-08-03: PL'S MOT FOR DEFAULT IS MOOT; DISC. & T/D RESET — Miscellaneous
2006-07-31: P'S MOTION FOR DEFAULT JUDGEMENT — Motions
2006-07-26: NOTICE OF DEFAULT SET ASIDE; LATE FILED ANSWER ACCEPTED; DISC. & T/D RESET — Miscellaneous
2006-07-24: ANSWER; RESP TO NOT. OF DEFAULT — Miscellaneous
2006-06-20: NOTICE OF DEFAULT — Defaults
2006-04-20: TRIAL DATES RESET — Scheduling
2006-04-19: CHANGE OF CORRESPONDENCE ADDRESS — Parties
2006-03-20: PENDING, INSTITUTED — Status
2006-03-20: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
2006-02-28: FILED AND FEE — Fees

Related